×
About 16,383 results

ALLMedicine™ Ascites Center

Research & Reviews  5,210 results

Development and external validation of nomograms for predicting individual survival in ...
https://doi.org/10.1002/cam4.5853
Cancer Medicine; Liu X, Lu H et. al.

Mar 28th, 2023 - Ovarian clear cell carcinoma (OCCC) is a distinct and highly malignant subtype of ovarian cancer with high individual heterogeneity in survival that requires specific prognostic predictive tools. Thus, this study aimed to construct and validate no...

Early paracentesis is associated with better prognosis compared to late or no-paracente...
https://doi.org/10.1097/LVT.0000000000000137
Liver Transplantation : Official Publication of the Ameri... Patel N, Silvey S et. al.

Mar 28th, 2023 - Guidelines recommend that all hospitalized patients with cirrhosis and ascites receive an early (<24 h from admission) paracentesis. However, national data are not available regarding compliance with and consequences of this quality metric. We uti...

Relationship between lipid profiles and reduced handgrip strength (dynapenia) in hospit...
https://doi.org/10.1097/MEG.0000000000002536
European Journal of Gastroenterology & Hepatology; Cui B, Hui Y et. al.

Mar 27th, 2023 - Dynapenia embraces clinical significance and predictive value separated from skeletal muscle loss among cirrhosis. Moreover, alterations in lipid levels may impact muscle function. It has yet to elucidate the relationship between lipid profiles an...

Glycogenic hepatopathy is associated with type 1 diabetes mellitus in only a minority o...
https://doi.org/10.1016/j.anndiagpath.2023.152130
Annals of Diagnostic Pathology; Cox BK, Guindi M et. al.

Mar 26th, 2023 - This study examines the clinical-pathological profiles of patients with glycogenic hepatopathy in a contemporary cohort of patients at an adult acute care hospital. Liver biopsies with glycogenic hepatopathy were retrieved from the departmental su...

Investigation into the Genetics of Fetal Congenital Lymphatic Anomalies.
https://doi.org/10.1002/pd.6345
Prenatal Diagnosis; Rogerson D, Alkelai A et. al.

Mar 25th, 2023 - Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants wh...

see more →

Guidelines  8 results

Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE...
https://doi.org/10.1055/a-1738-6780
Endoscopy van Wanrooij RLJ, Bronswijk M et. al.

Feb 4th, 2022 - 1:  ESGE recommends a prolonged course of a prophylactic broad-spectrum antibiotic in patients with ascites who are undergoing therapeutic endoscopic ultrasound (EUS) procedures.Strong recommendation, low quality evidence. 2:  ESGE recommends plac...

Non-invasive diagnosis and follow-up of portal hypertension.
https://doi.org/10.1016/j.clinre.2021.101767
Clinics and Research in Hepatology and Gastroenterology; Thabut D, Weil D et. al.

Aug 1st, 2021 - Compensated advanced chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension (CSPH, defined by a hepatic venous pressure gradient...

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and...
https://doi.org/10.1002/hep.31884
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 5th, 2021 - Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.|2021|Biggins SW,Angeli P,Garcia-Tsao G,Ginès P,Ling S...

Guidelines on the management of ascites in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788190
Gut Aithal GP, Palaniyappan N et. al.

Oct 18th, 2020 - The British Society of Gastroenterology in collaboration with British Association for the Study of the Liver has prepared this document. The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and managemen...

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166105
Clinical and Molecular Hepatology;

Jul 12th, 2018 - KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.|2018| ,|therapeutic use,therapeutic use,diagnosis,etiology,metabolism,therapy,therapeutic use,complications,diagnosis,therapy,complications,diagnosis,analysis,

see more →

Drugs  125 results see all →

Clinicaltrials.gov  611 results

Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites
https://clinicaltrials.gov/ct2/show/NCT03451292

Mar 23rd, 2023 - This is a phase 3, multicenter, randomized, controlled, parallel-group, and open-label clinical study to evaluate the efficacy of standard medical treatment (SMT) + Albutein 20% administration versus SMT alone in subjects with decompensated cirrho...

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

Mar 23rd, 2023 - Study Description: We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment na(SqrRoot) ve or experienced who have failed a prior treatment (includi...

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
https://clinicaltrials.gov/ct2/show/NCT01174121

Mar 17th, 2023 - Background: Metastatic digestive tract cancers, in particular esophageal, gastric, pancreatic and hepatobiliary carcinomas, are associated with poor survival beyond five years and poor response to existing therapies. Data from the National Cancer ...

Swiss Liver Venous Thrombosis Study
https://clinicaltrials.gov/ct2/show/NCT01983059

Mar 15th, 2023 - Background Outcome measures: Primary: Liver venous thrombosis recanalization Secondary: Thrombosis progression, Overall mortality, Major bleeding, Ascites Objective To start a prospective observational cohort study of Liver Venous Thrombosis patie...

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
https://clinicaltrials.gov/ct2/show/NCT05516498

Mar 10th, 2023 - Part A will assess the efficacy, safety, and tolerability of the combination of 2.5 mg zibotentan and 10 mg dapagliflozin versus placebo in participants with Child-Pugh A cirrhosis with features of portal hypertension and with no history of decomp...

see more →

News  570 results

Smaller Liver Transplant Candidates Wait Longer, Less Likely to Receive Organ
https://www.medpagetoday.com/transplantation/livertransplantation/103780

Mar 29th, 2023 - Liver transplant waitlist candidates who are smaller in size are significantly less likely than larger candidates to receive a liver transplant, contributing to a sex disparity in organ transplants, according to a retrospective study. After candid...

Update on secondary cytoreduction in recurrent ovarian cancer
https://www.mdedge.com/obgyn/article/260761/gynecologic-cancer/update-secondary-cytoreduction-recurrent-ovarian-cancer
Catherine John, MD, Katherine Tucker, MD

Jan 24th, 2023 - Recurrent ovarian cancer is difficult to treat; it has high recurrence rates and poor targeted treatment options. Between 60% and 75% of patients initially diagnosed with advanced-stage ovarian cancer will relapse within 2-3 years.

Abstinence Tied to Lower Mortality in Alcoholic Cirrhosis With Portal Hypertension
https://www.medpagetoday.com/gastroenterology/generalhepatology/102137

Dec 8th, 2022 - Alcohol abstinence was associated with improved prognosis across all stages of clinically significant portal hypertension in patients with alcohol-related cirrhosis, according to an observational study. Among 320 such patients, multivariable analy...

Disease progression pattern linked with poor prognosis in advanced gastric cancer patients on nivolumab
https://www.mdedge.com/hematology-oncology/article/259670/gastrointestinal-cancer/disease-progression-pattern-linked-poor

Nov 22nd, 2022 - Key clinical point: New lesions in different organs and appearance/increase in ascites, but not the originally defined characteristics of hyperprogressive disease (HPD), are disease progression patterns associated with poor prognosis in patients w.

Ubamatamab Monotherapy Elicits Responses in Heavily Pretreated Ovarian Cancer
https://www.onclive.com/view/ubamatamab-monotherapy-elicits-responses-in-heavily-pretreated-ovarian-cancer

Nov 17th, 2022 - Ubamatamab (REGN4018) monotherapy produced early clinical activity and an acceptable risk/benefit profile in heavily pretreated patients with ovarian cancer, according to data from a phase 1 trial (NCT03564340) presented at the 2022 ESMO Congress....

see more →

Patient Education  29 results see all →